770 Safety, efficacy, and pharmacokinetic results from a phase I first-in-human study of ABBV-151 with or without anti-PD1 mAb (budigalimab) in patients with locally advanced or metastatic solid tumors

التفاصيل البيبلوغرافية
العنوان: 770 Safety, efficacy, and pharmacokinetic results from a phase I first-in-human study of ABBV-151 with or without anti-PD1 mAb (budigalimab) in patients with locally advanced or metastatic solid tumors
المؤلفون: Tolcher, Anthony, Roda-Perez, Desamparados, He, Kai, Moreno, Victor, Gomez-Roca, Carlos, Machiels, Jean-Pascal, Razak, Albiruni, Sahtout, Mohammad, Guan, Xiaowen, Jaryno-Daly, Stacy, Leibman, Rachel, Blaney, Martha, O’Brien, James, Lorusso, Patricia, Powderly, John, Golan, Talia, Miller, Kathy, Bruix, Jordi
المصدر: Regular and Young Investigator Award Abstracts
بيانات النشر: BMJ Publishing Group Ltd
سنة النشر: 2022
نوع الوثيقة: conference object
اللغة: unknown
DOI: 10.1136/jitc-2022-sitc2022.0770
DOI: 10.1136/jitc-2022-SITC2022.0770
الإتاحة: https://doi.org/10.1136/jitc-2022-sitc2022.0770Test
رقم الانضمام: edsbas.27F602C6
قاعدة البيانات: BASE